Presence of ductal carcinoma in situ confers an improved prognosis for patients with T1N0M0 invasive breast carcinoma

AUTOR(ES)

Logullo, A.F., Godoy, A.B., Mourão-Neto, M., Simpson, A.J.G., Nishimoto, I.N., Brentani, M.M.

FONTE

Braz J Med Biol Res

DATA DE PUBLICAÇÃO

2002-08

RESUMO

We have retrospectively analyzed a series of 155 sequential cases of T1N0M0 ductal carcinomas of which 51 tumors had a ductal carcinoma in situ (DCIS) component for correlation between the presence of DCIS and clinicopathological variables, recurrence and patient survival. No correlations between the presence of DCIS and age, menopausal status, size, estrogen or progesterone receptors were found. High-grade infiltrative tumors tended not to present a DCIS component (P = 0.08). Patients with tumors associated with DCIS form a subgroup with few recurrences (P = 0.003) and good survival (P = 0.008). When tumors were classified by size, an association between large tumors (>1.0 cm) and increased recurrence and shortened overall survival was found. The presence of DCIS in this subgroup significantly reduced the relative risk of death.

Documentos Relacionados

• Metastatic breast carcinoma with appearance resembling micropapillary ductal carcinoma in situ.
• Myiasis associated with an invasive ductal carcinoma of the left breast: case study
• Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast
• The diagnosis and management of pre-invasive breast disease: Ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) – current definitions and classification
• Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward?